A positive CD4+ T-cell response was noted in 41% and 50% of CVID patients at week 6 and 16, respectively, while the combined CD4+/CD8+ assay showed a negative trend over time with 50% and 41% positive at week 6 and 16, respectively. This evidence concerns the gene CD4 and common variable immunodeficiency.